Teva to Present at Barclays Global Healthcare Conference and Leerink Partners Global Healthcare Conferences in March
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, ...
Is Teva Pharmaceuticals Industries Limited (TEVA) the Best Weight Loss Drug Stock to Buy According to Analysts?
We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...
Mylan's Copaxone Suit Against Teva Should Survive, Judge Says
Teva Pharmaceutical Industries Ltd.'s bid to dismiss antitrust claims should be denied in a case where Mylan Pharmaceuticals Inc. alleges the company unlawfully delayed a generic version of a multiple ...
Bronstein, Gewirtz & Grossman, LLC Encourages Corcept Therapeutics Incorporated (CORT) Investors to Inquire about Securities Investigation
NEW YORK CITY, NY / ACCESS Newswire / February 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential ...
CSR Wire3d
Spreading Hope: How Teva Is Improving Access to Medicines Across the Globe
In high-income countries, more than 80% of children diagnosed with cancer will survive. Yet in some low- and middle-income ...
Is Teva Pharmaceutical Industries Limited (TEVA) the Best Low Price Pharma Stock to Invest In Right Now?
We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to ...
CSR Wire5d
Behind the Numbers: Working To Tackle Breast Cancer in Ghana
Breast cancer remains a significant health challenge globally with approximately 2.3M new cases in 2022. While breast cancer ...
Business Insider6d
Bronstein, Gewirtz & Grossman, LLC Is Investigating Corcept Therapeutics Incorporated (CORT) And Encourages Stockholders to Connect
Investigation Details In August 2020, Teva Pharmaceutical Industries Limited ("Teva") received approval from the U.S. Food ...
The Bakersfield Californian10d
Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 ...
New detailed data from the RELIEVE UCCD study support overall efficacy and safety of duvakitug in all pre-specified subgroups across the different dosesNew endpoints presented include findings on clin ...